You can:
Name | Glucagon receptor |
---|---|
Species | Rattus norvegicus (Rat) |
Gene | Gcgr |
Synonym | GGR GL-R glucagon receptor GR |
Disease | N/A for non-human GPCRs |
Length | 485 |
Amino acid sequence | MLLTQLHCPYLLLLLVVLSCLPKAPSAQVMDFLFEKWKLYSDQCHHNLSLLPPPTELVCNRTFDKYSCWPDTPPNTTANISCPWYLPWYHKVQHRLVFKRCGPDGQWVRGPRGQSWRDASQCQMDDDEIEVQKGVAKMYSSYQVMYTVGYSLSLGALLLALVILLGLRKLHCTRNYIHGNLFASFVLKAGSVLVIDWLLKTRYSQKIGDDLSVSVWLSDGAVAGCRVATVIMQYGIIANYCWLLVEGVYLYSLLSITTFSEKSFFSLYLCIGWGSPLLFVIPWVVVKCLFENVQCWTSNDNMGFWWILRIPVLLAILINFFIFVRIIHLLVAKLRAHQMHYADYKFRLARSTLTLIPLLGVHEVVFAFVTDEHAQGTLRSTKLFFDLFFSSFQGLLVAVLYCFLNKEVQAELLRRWRRWQEGKALQEERMASSHGSHMAPAGTCHGDPCEKLQLMSAGSSSGTGCEPSAKTSLASSLPRLADSPT |
UniProt | P30082 |
Protein Data Bank | N/A |
GPCR-HGmod model | N/A |
3D structure model | No available structures or models |
BioLiP | N/A |
Therapeutic Target Database | N/A |
ChEMBL | CHEMBL4720 |
IUPHAR | 251 |
DrugBank | N/A |
Name | CID 44278221 |
---|---|
Molecular formula | C123H180N32O33S |
IUPAC name | (3S)-4-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-3-hydroxy-2-[[(2S)-3-(4-hydroxyphenyl)-2-(4-phenylbutanoylamino)propanoyl]amino]propanoyl]amino]hexanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]propanoyl]amino]-5-oxopentanoyl]amino]-4-oxobutanoic acid |
Molecular weight | 2667.04 |
Hydrogen bond acceptor | 37 |
Hydrogen bond donor | 37 |
XlogP | -6.9 |
Synonyms | N/A |
Inchi Key | HABLXTVBIQQLFS-AGWJQGOJSA-N |
Inchi ID | InChI=1S/C123H180N32O33S/c1-63(2)51-83(110(177)142-82(46-50-189-9)109(176)149-89(57-96(127)163)118(185)155-101(67(8)158)102(128)169)145-114(181)88(56-72-60-135-76-29-17-16-28-75(72)76)148-108(175)81(43-45-95(126)162)143-121(188)100(65(5)6)154-117(184)87(53-69-25-14-11-15-26-69)147-115(182)90(58-98(165)166)150-107(174)80(42-44-94(125)161)138-103(170)66(7)136-104(171)78(31-21-48-133-122(129)130)139-105(172)79(32-22-49-134-123(131)132)141-120(187)93(62-157)153-116(183)91(59-99(167)168)151-111(178)84(52-64(3)4)144-113(180)86(55-71-36-40-74(160)41-37-71)146-106(173)77(30-18-19-47-124)140-119(186)92(61-156)152-112(179)85(54-70-34-38-73(159)39-35-70)137-97(164)33-20-27-68-23-12-10-13-24-68/h10-17,23-26,28-29,34-41,60,63-67,77-93,100-101,135,156-160H,18-22,27,30-33,42-59,61-62,124H2,1-9H3,(H2,125,161)(H2,126,162)(H2,127,163)(H2,128,169)(H,136,171)(H,137,164)(H,138,170)(H,139,172)(H,140,186)(H,141,187)(H,142,177)(H,143,188)(H,144,180)(H,145,181)(H,146,173)(H,147,182)(H,148,175)(H,149,176)(H,150,174)(H,151,178)(H,152,179)(H,153,183)(H,154,184)(H,155,185)(H,165,166)(H,167,168)(H4,129,130,133)(H4,131,132,134)/t66-,67+,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,100-,101-/m0/s1 |
PubChem CID | 44278221 |
ChEMBL | CHEMBL413208 |
IUPHAR | N/A |
BindingDB | 50098566 |
DrugBank | N/A |
Structure | ![]() |
Lipinski's druglikeness | This ligand has more than 5 hydrogen bond donor. This ligand has more than 10 hydrogen bond acceptor. This ligand is heavier than 500 daltons. |
Parameter | Value | Reference | Database source |
---|---|---|---|
IC50 | 21.2 nM | PMID11311060 | BindingDB,ChEMBL |
Relative binding | 7.1 % | PMID11311060 | ChEMBL |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417